Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleIxazomib plus daratumumab and dexamethasone: Final analysis of a phase 2 study among patients with relapsed/refractory multiple myeloma.AuthorsDelimpasi, Sosana; Dimopoulos, Meletios A.; Straub, Jan; Symeonidis, Argiris; Pour, Luděk; Hájek, Roman; Touzeau, Cyrille; Bhanderi, Viralkumar K.; Berdeja, Jesus G.; Pavlíček, Petr; Matous, Jeffrey V.; Robak, Pawel J.; Suryanarayan, Kaveri; Miller, Alison; Villarreal, Miguel; Cherepanov, Dasha; Srimani, Jaydeep K.; Yao, Huilan; Labotka, Richard; Orlowski, Robert Z.PublicationAmerican Journal of Hematology, 2024, Vol 99, Issue 9, p1746ISSN0361-8609Publication typeArticleDOI10.1002/ajh.27382